The largest study to date of prostate cancer screening reinforces the existing evidence that the potential benefits of the test are outweighed by the harms of overtreatment for low-grade cancer that could be left untreated.
Combining multiple forms of radiation therapy with hormone treatments lengthens survival in men with aggressive prostate cancer.
Almost a decade ago, after exhausting treatment options for lung cancer, Linnea Olson was given only a few months to live. But her participation in an early clinical trial — targeting a then newly identified mutation associated with lung cancer — produced an amazing response. Living with what remains a terminal illness, Linnea is embracing new personal goals, experiencing a creative renewal, and appreciating every moment.
Men whose PSA levels continue rising even after surgery or radiation therapy may have a new treatment option with the approval of the drug apalutamide.
Medical screening tests can help detect problems before they become hard to treat. Many screening tests are recommended for adults or when a person has certain risk factors. But when should screening stop? A new study examines this issue for colonoscopies.
Men with prostate cancer that has spread outside the gland now have several newer drug options available for treatment, and research has found that taking any of them is likely to improve survival duration.
Women who choose breast reconstruction after mastectomy but are unhappy with the results have another option: fat grafting, in which liquefied tissue from another part of the body is injected into the reconstructed breast.
Precision medicine is an approach to fighting certain types of cancer that considers a person’s family history, environment, and health habits, along with genetic testing, to predict which medication will provide the most effective treatment.
An analysis of studies found an association between alcohol consumption and increased risk of certain skin cancers, but there is no solid evidence of a direct connection.
Surveys of over 900 men who were diagnosed with prostate cancer in the 1990s found that approximately 15% had some regret over their treatment choices. Study authors encourage doctors and patients to have frank and thorough discussions about about the risks and benefits of various forms of treatment for prostate cancer.